IDH1 and acute myeloid leukemia: The combination of proteomics, lipidomics, and isotopic profiling experiments allowed us to uncover a profound reprogramming of lipid metabolism in IDH1 mutant AML cells through a simultaneous increase of both FA oxidation and de novo lipogenesis.